Announced
Everlife-backed CPC Diagnostics completed the acquisition of the POCT division of Weldon Biotech and SM Biotech.
Synopsis
Everlife-backed CPC Diagnostics, a provider of clinical diagnostic products and services, completed the acquisition of the POCT division of Weldon Biotech, a manufacturer and distributor of in vitro diagnostic products, and SM Biotech, a unit of mushroom machinery manufacturing. Financial terms were not disclosed.
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.